Leadership Team
Our approach combines deep industry expertise across more than 150+ combined years in FDA approvals, women’s health launches, regulatory and clinical management, and commercialization.
Stephanie COLLINS, RN, BSN, BCPA
Founder and Chief Patient Officer
30 years of leadership in specialty, rare, and women’s health therapeutics.
Successfully launched 15 therapies with expertise in market development, payer strategy, and advocacy.
Recognized leader in policy, patient advocacy, and systems-level strategy, shaping guidelines and building ecosystems that enable first-in-class approvals.
Courtney RUTKOWSKI
Founder and Chief Engagement Officer
25+ years in healthcare and life sciences, including seven product launches in women’s health.
Built and scaled 14 top-performing commercial teams delivering growth above expectations.
Expert in market ecosystem building, commercial infrastructure development, and stakeholder engagement to drive adoption and access.
Board Members
Greg Shiffman, MBA
Board Chairman
Accomplished senior finance executive with more than 25 years of strategic and operational finance, treasury, corporate development, manufacturing, and logistics experience.
CFO of ABSCI, taking them through IPO in 2021. Prior CFO at Vineti, Lion Biotechnologies, Inc., renamed Iovance Biotherapeutics, Inc., and served as EVP and CFO at Stemcells, Inc., Dendreon Corp., and Affymetrix. VP & Controller at Applied BioSystems.
MBA, Northwestern University’s Kellogg School of Management
Kevin Helmbacher
Board Member
Seasoned legal executive with more than 30 years of experience leading the legal and compliance functions at both public and private companies in the life science and healthcare industry.
Mr. Helmbacher is currently the Senior Vice President of Legal and Compliance and General Counsel at Dendreon Pharmaceuticals.
